{"groups":[{"description":"Azacitidine, 75 mg/m\\^2/day given by subcutaneous injection for 7 days of every 28 day cycle, plus best supportive care.","id":"FG000","title":"Azacitidine"},{"description":"Physician choice of low dose cytarabine, standard chemotherapy, or best supportive care (consisting of blood products, growth factors, antibiotics)","id":"FG001","title":"Conventional Care"}],"periods":[{"dropWithdraws":[{"reasons":[{"groupId":"FG000","numSubjects":"19"},{"groupId":"FG001","numSubjects":"10"}],"type":"Adverse Event"},{"reasons":[{"groupId":"FG000","numSubjects":"1"},{"groupId":"FG001","numSubjects":"7"}],"type":"Protocol Violation"},{"reasons":[{"groupId":"FG000","numSubjects":"1"},{"groupId":"FG001","numSubjects":"1"}],"type":"Lost to Follow-up"},{"reasons":[{"groupId":"FG000","numSubjects":"15"},{"groupId":"FG001","numSubjects":"37"}],"type":"Withdrawal by Subject"},{"reasons":[{"groupId":"FG000","numSubjects":"0"},{"groupId":"FG001","numSubjects":"2"}],"type":"Physician Decision"},{"reasons":[{"groupId":"FG000","numSubjects":"11"},{"groupId":"FG001","numSubjects":"18"}],"type":"Lack of Efficacy"},{"reasons":[{"groupId":"FG000","numSubjects":"23"},{"groupId":"FG001","numSubjects":"20"}],"type":"Disease Progression"},{"reasons":[{"groupId":"FG000","numSubjects":"0"},{"groupId":"FG001","numSubjects":"1"}],"type":"Different Central+Local Pathology Review"},{"reasons":[{"groupId":"FG000","numSubjects":"0"},{"groupId":"FG001","numSubjects":"2"}],"type":"Not Documented"}],"milestones":[{"achievements":[{"groupId":"FG000","numSubjects":"179"},{"comment":"Best supportive care: 105, Low-dose cytarabine: 49, Standard chemotherapy: 25 patients","groupId":"FG001","numSubjects":"179"}],"type":"STARTED"},{"achievements":[{"comment":"Includes those who died or transformed to AML, or receiving drug + eligible for extension period.","groupId":"FG000","numSubjects":"109"},{"comment":"Includes patients who died or transformed to AML during treatment, or were still receiving drug.","groupId":"FG001","numSubjects":"81"}],"type":"COMPLETED"},{"achievements":[{"groupId":"FG000","numSubjects":"70"},{"groupId":"FG001","numSubjects":"98"}],"type":"NOT COMPLETED"}],"title":"Overall Study"}],"preAssignmentDetails":"738 patients screened from 98 investigator sites. Randomized patients contributed by 79 investigator sites."}